(Date:11/21/2008)...-FirstCall/ -- Alseres,Pharmaceuticals, Inc. (Nas... into,a securities purchase agreement with Robert...es of common stock of the Company, together with w...common stock at an exercise price of,$1.84 per sh.... The financing,resulted in total gross proceeds...
(Date:11/21/2008)...rneys representing consumers and,third-party paye...n settlement,with healthcare services giant McKes...any fraudulently inflated the price of more than 4...g benchmarks. , (Logo: http://www.newscom....e lawsuit, filed under the Racketeer Influenced an...
(Date:11/21/2008)...Call/ -- Escalon Medical Corp. (Nasdaq: ESMC ) t...eted a $1,100,000 private placement of common stoc... and institutional investors. The Company sold 1,... The investors also received warrants to purchase...n exercise price of $1.21 per share. The warrants...
(Date:11/21/2008)...ire-FirstCall/ -- DATATRAK,International, Inc. (N... focused,on global eClinical solutions for the cl...lliance partner in Japan, NTT DATA Corporation, ha...e DATATRAK eClinical platform into production,for...t of this first,independently designed clinical t...
Breaking Medicine News(10 mins):Health News:Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 2Health News:Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 3Health News:Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million 2Health News:Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million 3Health News:Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing 2Health News:Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing 3Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 2Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 3...made a formal announcement about providing Illinoi... to the tune of millions of dollars//, for executi...cials have been perturbed about cases of bird flu ...sed concerns of an impending worldwide pandemic. ...
...ists at University of California, has cautioned pa...ressive symptoms by seeking timely medical assista...toms of depression show a tendency to indulge in s...sing a questionnaire consisting of 19 parameters, ...
...ment has provided a grant of $6 million for the Fl...d research work for dyslexia in children.// The s...evention of the symptom. The grant will fund the ...ealth (NIH) Multidisciplinary Learning Disabilitie...
...ast cancer have warned others to be wary of the ma...n given a clean diagnosis in spite of having cance... Phillipa Naismith, 52, and Sandra Harley, 48, exp...cer within months of being given the all clear by ...
Other Medicine News:Health News:Research Fund for FSU to Eradicate Dyslexia 2Health News:BreastScreen Australia Is Being Sued Towards Medical Negligence 2(Date:11/20/2008)...ROMSO, Norway, November 20 The Sca...opharma has announced results of studies on its,l...ICAAC in Washington, DC,the studies showed that ...,bacteriocidal effect, significantly better toward... pyogenes than marketed gold standard drugs. In,a...
(Date:11/19/2008)...AND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ -...eda Oncology Company, a subsidiary of,Takeda Phar...unced that,enrollment in the Phase 3 MONET1 trial...th paclitaxel and carboplatin for the first-line t...NSCLC) has been temporarily suspended,following a...
(Date:11/19/2008)...ude scientists report basic findings on critical e...ow to better treat an array of disorders , , ...-- Scientists at St. Jude Children,s Research Hos...one of the body,s enzyme workhorses called calpain...rs, calpains function in many cellular processes, ...
(Date:11/19/2008)...K, Del., Nov. 19 Isogen, a contrac...sterile filling, today announced the first,phase ...n was founded to,specifically address the process...ted with the $2 billion highly-niched, low-volume ...ng market segment. , Companies can invest o...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Health Secretary Urges Pennsylvanians to Get a Flu Shot 2527 1Health Secretary Urges Pennsylvanians to Get a Flu Shot 2527 2Prestigious Bioethics Award for Scholar from Mexico 963 1Prestigious Bioethics Award for Scholar from Mexico 963 2Stop eating for two 3A obese moms to be should gain less weight than currently recommended 2520 1Stop eating for two 3A obese moms to be should gain less weight than currently recommended 2520 2PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets 2515 1PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets 2515 2PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets 2515 3...sults from a Children,s Oncology Group (COG) Study...y Annual Meeting -, CHICAGO, June 04, 2007 /PRNews...aceutical company focused on developing monoclonal...ases, today,announced that treatment with epratuzu...l tolerated in children with,B-precursor acute lym...
...l pre-specified subset analyses of progression-fre... demonstrate a reduction in,relative risk of disea... These analyses included prior Taxotere use,geogr...HICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Ph...ced the presentation of,additional data from the d...
Other Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7..., in shorter exam lanes, where images from a stand... individual charts are available. Charts are contr... CV-3000 Vision Testing System, using the CV Keypa...ingle letter, horizontal line or vertical line. Th...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector.
This isnt just another new stand weve come up with, this is absolutely revolutionary!
Topcon offers an all-metal Trial Frame that is durably constructed, yet lightweight. It features a practical screw-thread design that extends the life of the trial frame by allowing for easy replacem
Medicine Products: